Characteristics | Total | non-ECMO group | ECMO group | P-value |
---|---|---|---|---|
N = 168 (n, %) (x ± s) | N = 149 (n, %) (x ± s) | N = 19 (n, %) (x ± s) | ||
Treatments (n) | Â | Â | Â | Â |
Antibiotics | 145 (97.32%) | 126 (84.53%) | 19 (100.00%) | 0.65 |
Immunoglobulin | 162 (96.43%) | 145 (97.32%) | 17 (89.47%) | 0.08 |
Corticosteroid | 109 (64.88%) | 96 (64.43%) | 13 (68.42%) | 0.69 |
Mechanical ventilation (n) | Â | Â | Â | Â |
Conventional Mechanical ventilation | 41 (24.40%) | 22 (14.77%) | 19 (100.00%) | 0.00 |
High-frequency Oscillatory Ventilation | 19 (11.31%) | 4 (2.68%) | 15 (78.95%) | 0.00 |
FiO2 > 60% | 37 (22.02%) | 18 (12.08%) | 19 (100.00%) | 0.00 |
PIP > 30cmH2O | 27 (16.07%) | 15 (10.07%) | 12 (63.16%) | 0.00 |
PEEP > 8cmH2O | 27 (16.07%) | 10 (6.71%) | 16 (84.21%) | 0.00 |
CRRT | 15 (8.93%) | 3 (2.01%) | 12 (63.16%) | 0.00 |
Complication | Â | Â | Â | Â |
Respiratory failure | 47 (27.98%) | 28 (18.79%) | 19 (100.00%) | 0.00 |
ARDS | 18 (10.71%) | 3 (2.01%) | 15 (78.95%) | 0.00 |
Septic shock | 18 (10.71%) | 4 (2.68%) | 14 (73.68%) | 0.00 |
Acute renal failure | 4 (2.38%) | 0 (0.00%) | 4 (21.05%) | 0.00 |
Pneumorrhagia | 3 (1.79%) | 1 (0.67%) | 2 (10.53%) | 0.00 |
Gastrointestinal hemorrhage | 3 (1.79%) | 2 (1.19%) | 1 (5.26%) | 0.22 |
Heart failure | 2 (1.19%) | 0 (0.00%) | 2 (10.53%) | 0.00 |
Liver failure | 2 (1.19%) | 0 (0.00%) | 2 (10.53%) | 0.00 |
Outcomes | Â | Â | Â | Â |
The length of hospitalization (days) | 18.12 ± 13.08 | 15.82 ± 8.31 | 37.13 ± 25.31 | 0.00 |
Dead (n) | 13 (7.74%) | 6 (3.57%) | 7 (36.84%) | 0.00 |